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Background: Progressive autograft dilation and need for later reoperation remain major concerns of 
the Ross procedure. The study investigates the clinica  outcome after the Ross operation, including a 
longitudinal analysis of autograft dimensions over 25 years. 
Methods: From November 1991 to April 2019, 137 patients underwent a Ross procedure at the 
University Hospitals of UCL-Brussels and Ghent. Inclusion criteria were age≤18 years and pulmonary 
autograft implantation by root replacement. Outcome focused on survival, reoperation rate and 
autograft size evolution through linear mixed model analysis. 
Results: A Ross or Ross-Konno operation was performed in 110(80%) and 27(20%)patients at a 
median age of 10.4y(4.7-14.3) and 0.5y(0.04-5.2). Overall 10 and 20 year survival was 87±3% and 
85±3%, but 93±3% for isolated Ross patients. RVOT-conduit exchange was required in 20.3%, 
whereas autograft-related reoperation was performed in 14(10.7%) patients at a median interval of 
14y(9-16), respectively for aortic regurgitation(n=2) and autograft dilation(n=12).  
Autograft z-values increased significantly at the sinu  and sinotubular junction(STJ) compared to the 
annulus(Annulus:0.05±0.38/y - Sinus:0.14±0.25/y – STJ:0.17±0.34/y, p=0.015). The z-value slope for 
autograft dimensions was significantly steeper for R ss-Konno versus Ross patients(Annulus:p=0.029 
– Sinus:p<0.001 – STJ:p=0.012), and for children having aortic arch repair(Annulus:p=0.113 – 
Sinus:p=0.038 – STJ:p=0.029). 
Conclusions: The Ross operation offers children requiring aortic valve replacement(AVR) an 
excellent survival perspective, with an acceptable risk of autograft reoperation within the first 25 
years. Contrary to the autograft annulus, dilation of the sinus and STJ size is of concern. Closer 
surveillance of autograft dimensions might be required n patients who underwent a Ross-Konno 











The treatment of aortic valve disease in pediatric patients yields various options, from catheter-based 
balloon valvuloplasty or surgical valve repair to valve replacement. Despite improving results of 
valve-preserving techniques, the majority of these sick valves ultimately need to be replaced1-3. The 
Ross operation is the preferred alternative, based on obvious advantages as the lack of the prosthesis-
related complications, the avoidance of lifelong anticoagulation and the growth potential in younger 
children. Disadvantages as the creation of a dual valve disease by the obligatory need for a pulmonary 
valve substitute with limited durability, and a hazardous risk of autograft reoperation for dilation with 
or without valve dysfunction remain of concern4,5.  
Most studies focusing on the fate of the pulmonary autograft have follow-up times limited to 10-15 
years, or are confounded by mixing pediatric and adult patients. The Leiden group recently reported on 
a 22-year experience with the Ross procedure in a cohort comprising 74% pediatric and 26% adult 
patients. They found a cumulative incidence of autograft reoperation of 20-31% at 15 to 20 years, 
mainly for autograft dilation during the second decade after surgery, advancing this observation as 
worrisome6.  
The purpose of this study on 25 years of follow-up of the Ross procedure is to anticipate on the long-
term fate of the autograft through including a longitudinal analysis of autograft size, in order to 
identify eventual patient subgroups in need of increased vigilance for later adverse outcome. 
 
Patients and Methods 
The Ethical Committee of the University Hospital UCL St Luc-Brussels and University Hospital of 
Ghent approved this retrospective study (Brussels B0001530-403 - Ghent B670201732393), waiving 
the need for informed consent. All patients who underwent a Ross(-Konno) operation at both centers 
between November 1991 and April 2019 were included into a common database. Patient and operative 
data were obtained from medical records. To increase the uniformity of the study population between 
centers, only patients operated at an age≤18 years for a congenital aortic valve disease and with the 
pulmonary autograft implanted via root replacement were included. Patients in whom the pulmonary 
autograft was wrapped into a vascular prosthesis (n=4) and patients having a Ross operation for 










Regardless of differences in cardiopulmonary bypass and cardioplegia management between centers, 
the surgical technique of pulmonary autograft implantation as a root was comparable, performed with 
a single or double running suture and without specific reinforcement of proximal or distal 
anastomosis. In patients with additional subaortic narrowing, the left ventricular outflow tract(LVOT) 
was opened by a Konno septal ventriculoplasty. The interventricular septal defect was closed with a 
prosthetic patch or muscular flap attached to the pulmonary autograft, at the surgeon’s discretion. 
Reconstruction of the right ventricular outflow tract(RVOT) was preferentially performed with 
cryopreserved pulmonary homografts, but bovine jugular vein conduits were occasionally used in 
smaller children. 
Follow-up consisted of an annual clinical visit and transthoracic echocardiogram performed in-
hospital by the local cardiologists. For patients followed outside the hospital, echocardiographic 
reports from the referring cardiologist were considered. Routine echocardiographic examinations 
available since discharge were reviewed to obtain adequate autograft measurements at 3 levels: (1) the 
annulus at the leaflet insertion, (2) the sinus of Valsalva at its largest diameter, and (3) the sinotubular 
junction(STJ). Autograft dimensions were retrieved from parasternal long-axis view acquisitions in 
systole. At least 4 valid autograft measurements per individual patient during follow-up were required 
to be considered eligible for longitudinal analysis, u ing an assessment shortly after surgery and the 
last visit evaluation as respectively first and last reference. Absolute dimensions were then 
transformed into z-values to adjust for somatic growth, according to Sluysmans et al7. Change of z-
value during follow-up was calculated as the ratio of the difference between first and last 
measurement, and the time interval between both measur ments, expressed per year time unit.  
Assessment of autograft valve function was retrieved from the echocardiographic report at last clinical 
visit. Aortic regurgitation was graded semi-quantitatively on a scale 0 to 4, based on the depth and 
width of the regurgitant jet. 
Clinical and regular echocardiographic follow-up was complete for 96% of the survivors for a median 
follow-up of 10.1y(1.8-17.9), resulting in a cumulative follow-up of 1379 patient/years. For the Ross 
group, the median follow-up time and cumulative follow-up were respectively 11.5(4.1-19.6) and 










cumulative follow-up. Appropriate autograft size data were available for analysis in 86 out of 118 
survivors(73%), yielding a total of 867 examinations, or a median of 6(4-14) evaluations per patient. 
Due to inadequate image acquisition, only 610 valid STJ measurements were accounted. The serial 
echo follow-up covered a time lapse of more than 20 years in 19%(n=16), 15-20 years in 20%(n=17), 
10-15 in 26%(n=23), 5-10 years in 22%(n=19) and less than 5years in 13%(n=11). In 38 patients, data 
were incomplete or unavailable, mostly by external follow-up. 
 
Statistical Analysis 
Data are reported for the total cohort, and separately for the Ross and Ross-Konno subgroups. Data 
distribution normality was evaluated by Kolmogorov-Smirnov test and Q-Q plot. Normally distributed 
data were reported as mean ± standard deviation, and comparison between groups was based on 
unpaired t-test. Not-normally distributed data were given by median and interquartile range(25th-7 th 
percentile), and compared by Mann-Whitney test. Categorical data were reported as number and 
frequency, and compared between groups with Chi-square or Fisher’s exact test. 
Early mortality was defined as 30-day mortality. Survival was analyzed by Kaplan-Meier method, 
with log-rank testing for difference between groups. Cox-regression analysis was done to determine 
risk factors for late mortality. Competing risk analysis was used to estimate the cumulative incidence 
of all-cause reoperation and autograft or RVOT reoperation, with death as competing event. To 
provide exact information on the late reoperation rate, 30d-mortality patients were excluded from this
analysis. Fine-Gray modeling was performed to estimate the hazard function of risk factors for 
reoperation, expressed by hazard ratio(HR) and 95% confidence interval(CI).  
Analysis of autograft dimensions over time was performed using a linear mixed-effect model. 
Measurements in patients who required late autograft reoperation, were censored from the time of 
reoperation. In a first analysis, the evolution of autograft dimensions was compared in-between the 
defined levels, using the autograft level as fixed effect in interaction with follow-up time. Bonferroni 
correction was used to adjust for multiple comparisons. To account for variability in age at the time of 
surgery, and in sequence of time intervals of autograft measurements, factors potentially affecting the 










using the defined risk factor in interaction with time. Following factors were investigated: gender, age
at the time of Ross operation, Ross versus Ross/Konno subgroup, predominant hemodynamic lesion, 
associated cardiac disease, and previous/associated aortic arch repair(AAR). Differences between 
groups were reported for both intercept and slope of the autograft z-values. Assumptions on 
homoscedasticity and normality of the longitudinal d ta were tested on the model residuals. Model 
performance was based on the lowest Akaike information criterion. Graphical presentation of 
between-group variability of autograft size evolution was based on scatter dot distribution of 
individual measurements and Loess curve fitting to 90% of the group data. Statistical significance was
assumed for p<0.05. Statistical analysis was performed with SPSS 25.0(IBM, Armonk, NY, USA) and 
R-version 3.6.1(package cmp.rsk) in R (R-Foundation for Statistical Computing, Vienna, Austria). 
 
Results 
Patient data (table 1) 
According to the inclusion criteria, 137 patients underwent a Ross procedure at both centers, 
respectively 73(53%) patients at the Ghent University Hospital and 64(47%) at UCL-St Luc. Out of 
this cohort, 27(20%) children had a Ross-Konno procedure. The median age at surgery for the whole 
group was 7.6y(2.8-13.2). Ross-Konno patients were commonly younger(median age 0.5y(0.04-5.2) 
versus 10.4y(4.7-14.3) in Ross-patients, p<0.001); half of them were operated at infant age(Ross-
Konno:14(52%) versus Ross:11(10%), p<0.001). A previous aortic valve procedure was done in 60%, 
mainly as balloon valvuloplasty in Ross patients(Ross: 62% - Ross-Konno: 15%, p=0.003). This 
procedure was performed at least twice in 28(20%) patients. The aortic valve disease was isolated in 
89(65%) patients, the majority within the Ross group(77%). Prior or concomitant AAR was performed 
more frequently in Ross-Konno patients(59% versus 13%, p<0.001), in accordance with more 













Early mortality occurred in 15(11%) patients, significantly more in Ross-Konno than in Ross patients 
(n=9, 33% versus n=6, 6%, p<0.001). The overall survival was 88.9±2.7%, 86.8±3.0% and 85.4±3.3% 
at respectively 1, 10 and 20 years, revealing a significant survival difference at the cost of the Ross-
Konno group(p<0.001)(Figure 1). Survival at 10-20 years after a simple Ross procedure was 
93.1±2.5%. Multivariate analysis of risk factors for late mortality identified age at operation (HR 0.85, 
95%CI 0.74-0.97, p=0.013) and the Ross-Konno procedure (HR 3.59, 95%CI 1.25-10.33, p=0.018) as 
independent determinants (table 2). 
Echocardiographic assessment at last follow-up (excluding 3 patients treated with a mechanical 
prosthesis during autograft reoperation) revealed an excellent autograft valve function, with aortic 
regurgitation grade 0-1 and grade 2 in respectively 104(91%) and 10(9%) patients. None of the 
patients had aortic insufficiency grade 3-4. 
 
(b) Reoperation rate 
The all-cause reoperation rate of the whole cohort was 25.9%, resulting in a cumulative reoperation 
incidence of 24.5±2.9% and 39.7±5.3 % at 10 and 20 years. Ross-Konno patients required more 
frequently a reoperation over time than Ross patients, revealing a significant difference in cumulative 
reoperation incidence of 36.0±6.7% versus 11.8±1.4% at 10 year(p<0.001).  
Autograft-related reoperation was performed in 14(10.7%) patients at a median interval of 14y(9-16). 
The majority of autograft reoperations was performed in Ross patients(n=13, 12.1%), but 1 Ross-
Konno patient, showing no difference in autograft reoperation rate between groups(log-rank 
p=0.736)(figure 2). Reasons for autograft reoperation were critical autograft dilation(root 
diameter>55mm) with or without valve insufficiency(Ross: 11pts – Ross-Konno:1pt) and primary 
valve dysfunction due to autograft distortion in 2 Ross patients. Reoperation consisted of isolated 
AVR with mechanical prosthesis(n=1), a Bentall procedure(n=2), and valve-sparing root replacement 
by David(n=10) or Yacoub(n=1) technique. The low number of events precluded to identify risk 
factors for autograft reoperation.  
RVOT conduit replacement was required in 26(20.3%) patients and significantly more often in Ross-










valve implantation in 16 patients. The median interval to RVOT reoperation was overall 10.2y(4.0-
16.9), and was significantly shorter for Ross-Konno patients(3.3y(1.7-10.2) versus 11.2y(6.2-18.3), 
p=0.001). Univariate analysis revealed age(HR 0.88, 95%CI 0.81-0.96, p=0.004), Ross-Konno 
operation(HR 5.86, 95%CI 2.22-15.44, p<0.001) and associated complex cardiac disease(HR 3.78, 
95%CI 1.86-8.49, p=0.001) as significant predictors f  RVOT reoperation, and retained age(HR 0.91, 
95%CI 0.83-0.99, p=0.037) and complex cardiac defects(HR 3.12, 95%CI 1.26-7.75, p=0.014) at 
multivariate analysis. 
Other reinterventions were balloon dilation(n=4) or redo-aortic arch enlargement(n=1) for recurrent 
coarctation, closure of residual VSD(n=2) and pacemaker implantation(n=5). 
 
(c) Evolution of autograft dimensions 
The evolution of diameters and z-values at the autograft annulus, sinus and STJ in the whole cohort is 
shown in figure 4. The intercept z-values were significantly higher at the sinus and STJ than at the 
annulus(Annulus:1.8±0.9 – Sinus:3.3±3.1 – STJ:3.8±2.9, p<0.001), whereas the slope evolution 
remained stable for the annular z-values in contrast o both other levels(Annulus:0.05±0.38/y - 
Sinus:0.14±0.25/y – STJ:0.17±0.34/y, p=0.015). 
The mixed random-effect investigation of autograft measurements over time identified a significantly 
different evolution between Ross and Ross-Konno patients, and in children with associated AAR. 
Adequate autograft measurements were available in 75 Ross and 11 Ross-Konno patients. At the index 
operation, the annulus z-value at the intercept was in verage 2.24±0.42(p<0.001) higher in Ross than 
in Ross-Konno patients, while the z-value slope wassteeper in Ross-Konno patients(mean difference 
0.05±0.13/y, p=0.029). Similar observations were made for the sinus z-values(mean intercept 
difference 2.85±0.50, p<0.001 in favor of Ross; mean slope difference 0.12±0.17/y, p<0.001 in favor 
of Ross-Konno), and for the STJ z-values(mean intercept difference 2.69±0.58, p<0,001 in favor of 
Ross; mean slope difference 0.10±0.16/y, p=0.012) in favor of Ross-Konno)(figure 5a-c). 
Autograft size evolution was also significantly influenced by previous or concomitant AAR, 
represented by data of 16 patients. The mean z-value difference at the intercept was higher at all levels 










p<0.001). However, the z-value slope expressed as z-v lue change/year was higher in patients with 
AAR at the sinus(p=0.038) and STJ(p=0.024) but not at the annulus(p=0.113)(figure 6). 
Other factors like age, gender, type of valve dysfunction and associated cardiac disease had no 
significant effect on autograft size evolution. 
 
Comment 
In children and young adolescents presenting with aortic valve dysfunction unamenable to successful 
repair is the Ross procedure the preferred option for AVR. The survival after a Ross operation is 
exceeding 90% at 10 to 20 years in experienced centers, yielding generally few deaths beyond the 
early postoperative period4,6,8. This study confirmed the excellent survival perspctive in patients after 
a simple Ross operation, but revealed younger age at th  time of surgery and the need of a Ross-
Konno procedure as independent risk factors for late mortality. This finding has been identified by 
other groups also9-11. The need for AVR in early infancy is usually a surrogate for the precarious 
hemodynamic condition or the complexity of the underlying cardiac malformation requiring early 
intervention, which might be particularly the case for the Ross-Konno subgroup. 
Through including a longitudinal analysis of autograft dimensions over a longer time span, the 
principal focus of this study was to address the long-term fate of the pulmonary autograft in a pediatric 
population. To improve the uniformity of the study cohort, inclusion was restricted to patients of 18 
years or younger, all treated by a root replacement technique. Congenital aortic valve stenosis was the 
main predisposing disease, commonly presenting recurrent stenosis or mixed hemodynamic lesions 
after previous attempts of balloon dilation or occasionally surgical valvuloplasty.  
Comparison of the autograft evolution amongst studies is hindered by several factors. Many studies 
are mixing up pediatric and adult Ross patients, and are thereby frequently contaminated by acquired 
valve pathologies as endocarditis. Such series are consequently including a larger proportion of 
patients with primary aortic regurgitation, a hemodynamic burden known to enhance the risk of 
autograft dilation12,13. Our serial analysis of autograft size showed that (1) he autograft has a higher z-
value at the sinus and STJ compared to the annulus directly after implantation, and (2) the autograft 










stable evolution of the annulus. Horer et al. made similar observations in 48 children with a mean age
of 10 years during a shorter follow-up time of 5.1 years14. Accordingly, the first observation is 
attributed to the originally larger size of the pulmonary root compared to the aortic one, and to the 
immediate adaptive remodeling of the pulmonary rootexposed to systemic pressures. However, the 
dilation progress at the sinus and STJ in their analysis appeared to be faster, yielding an annual z-value 
increase of 0.5 and 0.7 respectively. Compared to the respective slopes of 0.14 and 0.17 at the sinus 
and STJ, our data are favoring a more optimistic perspective on the autograft progression over 20 
years.  
Two subgroups at risk for enhanced dilation have been identified, i.e. children who had a Ross-Konno 
procedure and those after previous AAR. To our knowledge, such information has yet not been 
revealed. Ross-Konno patients demonstrated a higher z-value progression at the sinus and STJ, but 
also at the annulus. Although speculative, partial absence of a fixed annular support at the region of 
the interventricular septal enlargement might possibly explain this finding. However, confounding 
with the other promoting factor, aortic arch surgery, is not excluded as Ross-Konno patients have 
more frequently associated aortic arch malformations. The effect of aortic stiffening after prior AAR, 
even for a simple localized coarctation, on vascular remodeling of the proximal aorta has already been 
shown, especially when the extracellular matrix is abnormal or weakened - as in the pulmonary 
autograft15-17. Hence, the low number of patients and the shorter follow-up of maximal 15 years in 
both subgroups ask for cautious interpretation and further validation by close surveillance. 
Lo Rito et al. found a significant effect of age at the time of Ross surgery on autograft size 
progression. The autograft size stability was better in children operated at an age less than 18 months, 
compared to older peers, which they attributed to an improved natural adaptation through intrinsically 
identical histological features of the foetal pulmonary and aortic root18. In our analysis, integrating age 
as continuous variable, the autograft size evolved independently of the children’s age at surgery. 
Preoperative aortic regurgitation is also associated with pathological autograft dilation, but mainly 
documented in series comprising adult patients5,12,13. It is conceivable that the effect of this factor in 











Late autograft reoperation was required in 11%, mainly for progressive root dilation, resulting in a 
cumulative incidence for autograft reoperation of 21.5±7.2% at 20 years. Despite comparable results 
during the first decade, the autograft reoperation rate in our series competes favorably with the 62% 
freedom from reoperation at 18 years in the Rotterdam study, and the cumulative incidence of 
autograft reoperation of 31% at 20 years by Schneider et al.6,12. The former study concerned equally 
younger patients operated before the age of 18 years, whereas the latter study comprised 26% adult 
patients. Considering that autograft dilation is the principal opponent of the long-term durability of the 
Ross operation, and that this process seems constant at the level of the sinus and STJ, the expectation 
for late autograft reoperation might achieve a significant magnitude beyond the second decade after 
the Ross procedure. Therefore, adopting root reinforcing techniques like inclusion into a vascular 
prosthesis or subcoronary autograft implantation are advisable in the teenaged Ross candidates19. 
Solutions for smaller infants are less evident, but in this specific cohort, the advantage of the Ross 
operation in terms of survival and valve-related complications needs to be outweighed with the risk of 
later autograft reoperation. 
 
Limitations  
Despite the representative sample-size and the use of linear mixed models, a statistical method robust 
to missing values for repeated measurements over a long time span, this study would have been better 
served by a prospective design including the systematic measurement of autograft dimensions during 
serial follow-up. Hence, the limitations inherent to the retrospective design are minimized by the 
completeness of clinical follow-up, concentrated on a purely pediatric population treated uniformly by 
autograft root implantation. Nonetheless, longer term data on specific subgroups characterized by a 
lower number of patients at risk such as those withcomplex cardiac malformations requiring a Ross-
Konno procedure, are mandatory. 
Since this study was mainly focused on the autograft outcome, specific information on RVOT conduit 
characteristics as size and type was lacking. Therefore, analysis of risk factors for RVOT conduit 












In this pediatric population up to 18 years of age, th  Ross operation is an excellent option for AVR, 
offering a 94% survival during the first 2 decades of life, with a very low risk of death beyond the 
early postoperative period. The prognosis is however poorer for infants with more complex cardiac 
malformations in whom relief of the LVOT requires a Ross-Konno procedure. 
The issue of treating a single valve disease by induci g potentially a double valve problem is pertinent 
as over 20 years, half of the patients had a reintervention, dominated by the need for RVOT conduit 
replacement. Although approximately 80% of this pediatric cohort remained free from autograft 
reoperation within this time frame, progressive autograft dilation remains a concern. Since this study 
demonstrated a constant increase of autograft dimensions particularly at the level of the sinus and 
sinotubular junction, the expectancy regarding freedom from autograft reoperation during the third 
decade or beyond might look worrisome, and justify additional technical measures at the time of 
autograft implantation aiming to control this pathological process. Moreover, serial follow-up of 
autograft size revealed a tendency for enhanced autograf  dilation in children after previous Ross-












Table 1. Patient data 
 Total Ross Ross-Konno P-value 














Male 97(71) 82(75) 15(56) 0.102 


























Isolated AoV disease 










































Associated Ao Arch surgery 
Patch repair 













Legend : Values are represented as n(%) or median(IQR) 
AoV= aortic valve; VSD=ventricular septal defect; cAVSD=complete atrioventricular septal defect; 












Table 2. Univariate and multivariate risk factor analysis for late mortality  
 Univariate analysis Multivariate analysis 
 HR 95%CI p-value HR 95%CI p-value 
Age 0.79 0.70-0.90 <0.001 0.85 0.74-0.97 0.013 
Gender(female to male) 0.84 0.32-2.24 0.727    
Ross-Konno versus Ross 8.20 3.15-21.31 <0.001 3.59 1.25-10.33 0.018 
Associated cardiac disease 5.40 1.92-15.18 0.001    
Genetic syndrome 2.37 0.68-8.17 0.174    













Figure 1: Survival plot of Ross/Ross-Konno patients 
Figure 2: Cumulative incidence of autograft reoperation for R ss/Ross-Konno patients 
Figure 3: Cumulative incidence of RVOT reoperation for Ross/Ross-Konno patients 
Figure 4:  
Left: Evolution of autograft diameters at annulus, sinus and STJ 
   Right: Evolution of autograft z-values at annulus, sinus and STJ 
Lines represent the Loess curve with 90% fit to the data, according to annulus(blue), 
sinus(red) and STJ(green) 
Figure 5: 
(a) Evolution of annulus diameters(left) and z-values(right): comparison between Ross and 
Ross-Konno patients 
(b) Evolution of sinus diameters(left) and z-values(right): comparison between Ross and 
Ross-Konno patients 
(c) Evolution of STJ diameters(left) and z-values(right): comparison between Ross and Ross-
Konno patients 
Lines represent the Loess curve with 90% fit to the data, according to Ross(blue) and Ross-
Konno(red) 
Figure 6: Mean z-value change/year for annulus, sinus and STJ: comparison between patients 
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